PharmaShots | Incisive News in 3 Shots

Subscribe Now

mCRC

Henlius Reports First Patient Dosing in P-II/III Study of HLX10 + HLX04 (biosimilar- bevacizumab) for 1L mCRC

Henlius Reports First Patient Dosing in P-II/III Study of HLX10 + HLX04 (biosimilar- bevacizumab) for 1L mCRC

March 11, 2021

Henlius Presents Results of HLX04 (biosimilar- bevacizumab) in P-III Study at ESMO Asia 2020

Henlius Presents Results of HLX04 (biosimilar- bevacizumab) in P-III Study at ESMO Asia 2020

November 20, 2020

Solasia Signs a License Agreement with Isofol to Develop and Commercialize Arfolitixorin for mCRC in Japan

Solasia Signs a License Agreement with Isofol to Develop and Commercialize Arfolitixorin for mCRC in Japan

August 14, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us